
<DOC>
<DOCNO>
WSJ900531-0020
</DOCNO>
<DOCID>
900531-0020.
</DOCID>
<HL>
   Business Brief -- St. Ives Laboratories Corp.:
   California Couple Increase
   Stake in Common to 15.67%
</HL>
<DATE>
05/31/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE A6
</SO>
<CO>
   SWIS
</CO>
<IN>
TENDER OFFERS, MERGERS, ACQUISITIONS (TNM)
</IN>
<LP>
   Stephen J. Redding, president of Stephen Redding &amp;
Associates Inc., Santa Barbara, Calif., said he and his wife,
Angelina, raised their stake in St. Ives Laboratories Corp.,
a Chatsworth, Calif., maker of beauty and personal-care
products, to 15.67% of the common shares outstanding.
   In a Securities and Exchange Commission filing, the
Reddings said they hold 1,086,000 St. Ives shares, including
107,500 bought from March 22 to May 18 for $7.875 to $8.625
apiece. In national over-the-counter trading yesterday, St.
Ives shares closed at $7.50, up 12.5 cents. The Reddings said
in the filing that they acquired the St. Ives stock as an
investment and that they may purchase more shares. St. Ives
declined to comment on the filing.
</LP>
<TEXT>
</TEXT>
</DOC>